The present study aimed to evaluate the new water soluble camptothecin analogue Namitecan (ST1968) in preclinical paediatric tumour models of the nervous system comprehensive of neuroblastoma, primitive neuroectodermal tumours/PNET and medulloblastoma where the drug was compared to Irinotecan.

Meco, D., Di Francesco, A. M., Cusano, G., Bucci, F., Pierri, F., Patriarca, V., Torella, A., Pisano, C., Riccardi, R., Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models, <<CANCER CHEMOTHERAPY AND PHARMACOLOGY>>, 2012; 70 (6): 811-822. [doi:10.1007/s00280-012-1973-0] [http://hdl.handle.net/10807/39351]

Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models

Meco, Daniela;Di Francesco, Angela Maria;Pierri, Filomena;Riccardi, Riccardo
2012

Abstract

The present study aimed to evaluate the new water soluble camptothecin analogue Namitecan (ST1968) in preclinical paediatric tumour models of the nervous system comprehensive of neuroblastoma, primitive neuroectodermal tumours/PNET and medulloblastoma where the drug was compared to Irinotecan.
Inglese
Meco, D., Di Francesco, A. M., Cusano, G., Bucci, F., Pierri, F., Patriarca, V., Torella, A., Pisano, C., Riccardi, R., Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models, <<CANCER CHEMOTHERAPY AND PHARMACOLOGY>>, 2012; 70 (6): 811-822. [doi:10.1007/s00280-012-1973-0] [http://hdl.handle.net/10807/39351]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/39351
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact